New Indication: Crizotinib for ALK-positive inflammatory myofibroblastic tumor
|New Indication: Crizotinib for ALK-positive inflammatory myofibroblastic tumor|
Am J Hematol. 2018 May;93(5):607-614.
Gambacorti-Passerini C, Orlov S, Zhang L, et al. Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label study.
Reviewed by Hasan Çağrı Yıldırım, MD on Aug 16, 2022
Altai Chemo Planner
Quickly Prepare Accurate Chemotherapy Orders
Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.